Home » ICMR tie up with Bharat Biotech...

ICMR tie up with Bharat Biotech for Indian COVID-19 vaccine

The Indian Council for Medical Research (ICMR) tie-up with Bharat Biotech to develop indigenous COVID-19 vaccine.

Sumit Arora Last updated on September 12th, 2024 11:09 am Leave a comment

The Indian Council for Medical Research (ICMR) tie-up with Bharat Biotech to develop indigenous COVID-19 vaccine. The vaccine is to be developed using virus strains that have been isolated from COVD-19 patients at ICMR’s National Institute of Virology (NIV), Pune.

ICMR has shared one of the 11 virus strains that it managed to culture with Bharat Biotech. The industry partnership is to develop the vaccine candidate and ICMR has transferred the technology to them One of the strains has now been successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL) in Hyderabad as part of the partnership. ICMR-NIV will provide continuous support to BBIL for vaccine development.

Important takeaways for all competitive exams

Director-General of ICMR: Balram Bhargava.
Headquarters of ICMR: New Delhi.

About the Author

Sumit Arora

Author

As a team lead and current affairs writer at Adda247, my role involves researching and creating informative and engaging content aimed at helping candidates prepare for national and state-level competitive government exams. I specialize in delivering insightful articles that keep aspirants updated on the latest current affairs trends and developments. My primary focus is on educational excellence, ensuring that our readers are well-prepared and informed to face their exams with confidence. Through meticulously crafted content, I aim to guide and support candidates in their journey toward success.